Bank of America
KRTX

Bank of America’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bank of America’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-110,962
Closed -$35.1M – 8333
2023
Q4 		$35.1M Buy
110,962
+7,109
+7% +$1.38M ﹤0.01% 1628
2023
Q3 		$17.6M Buy
103,853
+4,058
+4% +$763K ﹤0.01% 2169
2023
Q2 		$21.6M Sell
99,795
-132,397
-57% -$28.4M ﹤0.01% 1960
2023
Q1 		$42.2M Buy
232,192
+162,136
+231% +$31M ﹤0.01% 1494
2022
Q4 		$13.8M Buy
70,056
+13,150
+23% +$2.82M ﹤0.01% 2374
2022
Q3 		$12.8M Sell
56,906
-5,816
-9% -$1.18M ﹤0.01% 2356
2022
Q2 		$7.93M Sell
62,722
-23,839
-28% -$2.74M ﹤0.01% 2918
2022
Q1 		$11M Buy
86,561
+41,462
+92% +$4.67M ﹤0.01% 2769
2021
Q4 		$5.91M Buy
45,099
+20,451
+83% +$2.64M ﹤0.01% 3480
2021
Q3 		$3.02M Buy
24,648
+136
+0.6% +$15.7K ﹤0.01% 4060
2021
Q2 		$2.79M Sell
24,512
-5,576
-19% -$652K ﹤0.01% 4044
2021
Q1 		$3.62M Buy
30,088
+5,695
+23% +$645K ﹤0.01% 3720
2020
Q4 		$2.48M Sell
24,393
-14,058
-37% -$1.3M ﹤0.01% 3760
2020
Q3 		$2.97M Buy
38,451
+9,739
+34% +$830K ﹤0.01% 3374
2020
Q2 		$3.2M Buy
28,712
+9,843
+52% +$856K ﹤0.01% 3249
2020
Q1 		$1.36M Buy
18,869
+12,352
+190% +$1.06M ﹤0.01% 3806
2019
Q4 		$491K Buy
6,517
+3,902
+149% +$171K ﹤0.01% 5020
2019
Q3 		$42K Buy
2,615
+2,167
+484% +$42.1K ﹤0.01% 6380
2019
Q2 		$9K Buy
+448
New +$8.97K ﹤0.01% 6753

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Bank of America's KRTX Position: Q1 2024 in Review

Bank of America sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 110,962 shares — an estimated $35.1M sold.

Bank of America first reported a position in KRTX in Q2 2019 and held it in 19 quarters. The position peaked at $42.2M in Q1 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Bank of America reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 110,962 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $35.1M.
  • Bank of America first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
  • Bank of America's Karuna Therapeutics, Inc. Common Stock position peaked at $42.2M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.